SP
THC icon

Saranac Partners’s Tenet Healthcare THC Stock Holding History

Saranac Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Buy
2,463
+95
+4% +$17.5K 0.13% 75
2026
Q1 		$462K Sell
2,368
-95
-4% -$20K 0.2% 61
2025
Q4 		$489K Hold
2,463
– – 0.19% 52
2025
Q3 		$500K Buy
2,463
+210
+9% +$37.3K 0.09% 131
2025
Q2 		$397K Buy
2,253
+600
+36% +$90.3K 0.21% 55
2025
Q1 		$222K Buy
+1,653
New +$218K 0.13% 71
2024
Q3 		– Sell
-2,300
Closed -$306K – 62
2024
Q2 		$306K Hold
2,300
– – 0.18% 58
2024
Q1 		$242K Buy
+2,300
New +$207K 0.15% 71

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Saranac Partners's THC Position: Q2 2026 in Review

Saranac Partners increased its Tenet Healthcare (THC) stake by 4% in Q2 2026, buying an estimated $17.5K and bringing the position to 2,463 shares worth $461K. The position accounts for 0.13% of the portfolio, ranked #75.

Saranac Partners first reported a position in THC in Q1 2024 and has held it in 8 quarters since. The position peaked at $500K in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Saranac Partners held 2,463 shares of Tenet Healthcare worth $461K as of Q2 2026.
  • Saranac Partners bought 95 Tenet Healthcare shares in Q2 2026, an estimated $17.5K.
  • Tenet Healthcare made up 0.13% of Saranac Partners's portfolio in Q2 2026, its #75 holding.
  • Saranac Partners first reported a position in Tenet Healthcare in Q1 2024 and has held it in 8 quarters since.
  • Saranac Partners's Tenet Healthcare position peaked at $500K in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.